Literature DB >> 25314275

Super-refractory status epilepticus in West China.

L Tian1, Y Li1, X Xue2, M Wu2, F Liu2, X Hao1, D Zhou1.   

Abstract

OBJECTIVE: This study aims to determine the general frequency, mortality, and risk factors of super-refractory status epilepticus (SRSE) versus non-refractory status epilepticus (NRSE) and refractory status epilepticus (RSE).
METHODS: This work is a retrospective study. Clinical data of patients who were diagnosed with status epilepticus (SE) in the neurological ward and neuro-intensive care unit of West China Hospital from January 2009 to December 2012 were collected and analyzed.
RESULTS: A total of 98 patients were included in the study. The percentages of NRSE, RSE, and SRSE were 67.3%, 20.4%, and 12.2%, respectively. Convulsive SE was the main seizure type among the three groups. The most common cause of NRSE was related to epilepsy (EP). However, 67.7% of SRSE cases were caused by acute encephalitis. Moreover, 47% of SE and 40% of RSE cases had a history of EP, whereas only 8.3% of SRSE cases had such history (P < 0.01). The percentage of patients with STESS ≤2 was lowest in the SRSE group without statistical significance (P > 0.05). The general mortality of SE was 7.1%, whereas that of SRSE was 50%. During follow-up, most SRSE patients who survived have developed symptomatic EP.
CONCLUSIONS: This study was the first to use the statistical percentage of SRSE. Approximately 12.2% of SE cases will result in SRSE, which is a challenging medical situation for doctors. Patients with first episodes and acute encephalitis were also prone to develop SRSE.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  refractory status epilepticus; status epilepticus; super-refractory status epilepticus

Mesh:

Year:  2014        PMID: 25314275     DOI: 10.1111/ane.12336

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

Review 1.  Super-Refractory Status Epilepticus.

Authors:  Mauricio Ruiz Cuero; Panayiotis N Varelas
Journal:  Curr Neurol Neurosci Rep       Date:  2015-11       Impact factor: 5.081

Review 2.  Efficacy and safety of VNS therapy or continued medication management for treatment of adults with drug-resistant epilepsy: systematic review and meta-analysis.

Authors:  Sarah Batson; Rohit Shankar; Joan Conry; Jane Boggs; Rodney Radtke; Stephen Mitchell; Francesca Barion; Joanna Murphy; Vanessa Danielson
Journal:  J Neurol       Date:  2022-01-16       Impact factor: 6.682

3.  Unexpected Aphasia following Right Temporal Lobectomy as Treatment of Recurrent Super-Refractory Status Epilepticus.

Authors:  Utku Uysal; Patrick Landazuri; Caleb Pearson; Manoj Mittal; Nancy Hammond
Journal:  Case Rep Neurol       Date:  2017-08-23

4.  Multimodal Predictions of Super-Refractory Status Epilepticus and Outcome in Status Epilepticus Due to Acute Encephalitis.

Authors:  Fang Yuan; Fang Yang; Ruihua Jia; Wen Li; Yongli Jiang; Jingjing Zhao; Wen Jiang
Journal:  Front Neurol       Date:  2018-10-08       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.